ExLibris header image
SFX Logo
Title: Reflections from Science
Source:

Scientific American [0036-8733] DiChristina, Mariette yr:2011


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Griffiths, R. "GOOD AND BAD TRIPS." Scientific American 304.4 (2011): 8-8. Link to SFX for this item
2. Griffiths, Roland R. "Hallucinogens as Medicine." Scientific American 303.6 (2010): 76-79. Link to SFX for this item
3. "Medicine: More Bad Trips on LSD." Time 89.21 (1967). Link to SFX for this item
4. "GOOD AND BAD TRIPS REPLY." Scientific American 304.4 (2011): 8-. Link to SFX for this item
5. Vollenweider, Franz X. "Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies." Journal of psychopharmacology 25.11 (2010): 1434-1452. Link to Full Text for this item Link to SFX for this item
6. MacLean, Roland A. "Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness." Journal of psychopharmacology 25.11 (2011): 1453-1461. Link to Full Text for this item Link to SFX for this item
7. Grob, Charles S. "Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer." Archives of general psychiatry 68.1 (2010): 71-78. Link to SFX for this item
8. Hasler, F. "Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study." Psychopharmacology 172.2 (2004): 145-56. Link to SFX for this item
9. TIERNEY, J. "Hallucinogens Have Scientists Tuning In Again." New York Times 159.55,008 (2010): 1-1. Link to SFX for this item
10. Johnson, W. "Human hallucinogen research : Guidelines for safety." Journal of psychopharmacology 22.6 (2008): 603-620. Link to Full Text for this item Link to SFX for this item
11. Vollenweider, Franz X. "The neurobiology of psychedelic drugs: implications for the treatment of mood disorders." Nature Reviews. Neuroscience 11.9 (2010): 642-651. Link to SFX for this item
12. Vollenweider, F X X. "Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis." Neuropsychopharmacology 16.5 (1997): 357-72. Link to Full Text for this item Link to SFX for this item
13. Nichols, D. "Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al." Psychopharmacology 187.3 (2006): 284-288. Link to SFX for this item
14. Gorman, C. "Bad trips for the doubly troubled; a new study offers hope for the mentally ill drug user." Time 130 (1987): 58-. Link to SFX for this item
15. Lucas, M. "On not passing the acid test: bad trips and initiation." Anthropology of consciousness 16.1 (2005): 25-50. Link to Full Text for this item Link to SFX for this item
16. Lucas, M. "Inanna: goddess of bad trips." Re-vision 25.3 (2003): 30-39. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced